Functional adrenal zonation and regulation of aldosterone biosynthesis

Current Opinion in Endocrinology and Diabetes

Volumn 5, Issue 3, 1998, Pages 175-182

  Rainey, William E ^a   White, Perrin ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; ALDOSTERONE; ANGIOTENSIN; CALMODULIN; CAPTOPRIL; CIS ACTING ELEMENT; CORTICOTROPIN; POTASSIUM; STEROID 11BETA MONOOXYGENASE;

ADRENAL FUNCTION; ALDOSTERONE RELEASE; CALCIUM CELL LEVEL; DNA FLANKING REGION; ELECTROLYTE BALANCE; ENZYME REGULATION; FLUID BALANCE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR DYNAMICS; REVIEW; ZONA GLOMERULOSA;

EID: 0031835548     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-199806000-00005     Document Type: Review

References (86)

1. Arnold J: Ein Beitrag zu der feiner Struktur und dem Chemismus der Nebennieren. Arch Pathol Anat Physiol Klin Med 1866, 35:64-107.
2. Domalik LJ, Chaplin DD, Kirkman MS, Wu RC, Liu WW, Howard TA, et al.: Different isozymes of mouse 11 beta-hydroxylase produce mineralocorticoids and glucocorticoids. Mol Endocrinol 1991, 5:1953-1861.
3. Ogishima T, Suzuki H, Hata J, Mitani F, Ishimura Y: Zone-specific expression of aldosterone synthase cytochrome P-450 and cytochrome P-45011 beta in rat adrenal cortex: histochemical basis for the functional zonation. Endocrinology 1992, 130:2971-2977.
4. Lehoux JG, Martel D, Lehoux J, Ducharme L, Lefebvre A, Briere N: P450aldo in hamster adrenal cortex: immunofluorescent and immuno-gold electron microscopic studies. Endocr Res 1995, 21:275-280.
5. Pascoe L, Jeunemaitre X, Lerethon MC, Curnow KM, Gomez-Sanchez CE, Gasc JM, et al.: Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree. J Clin Invest 1995, 96:2236-2246.
6. Erdmann B, Gerst H, Bulow H, Lenz D, Bahr V, Bernhardt R: Zone-specific localization of cytochrome P45011B1 in human adrenal tissue by PCR-derived riboprobes. Histochem Cell Biol 1995, 104:301-307.
7. Mornet E, Dupont J, Vitek A, White PC: Characterization of two genes encoding human steroid 11 beta-hydroxylase (P450(11) beta). J Biol Chem 1989, 264:20961-20967.
8. Chua SC, Szabo P, Vitek A, Grzeschnik KH, John M, White PC: Cloning of cDNA encoding steroid 11 beta-hydroxylase (P450c11). Proc Natl Acad Sci U S A 1987, 84:7193-7197.
9. Kawamoto T, Mitsuuchi Y, Toda K, Yokoyama Y, Miyahara K, Miura S, et al.: Role of steroid 11β-hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans. Proc Natl Acad Sci U S A 1992, 89:1458-1462.
10. Pascoe L, Cumow KM, Slutsker L, Connell, JM, Speiser PW, New MI, et al.: Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2. Proc Natl Acad Sci U S A 1992, 89:8327-8331.
11. Lifton RP, Dluhy RG, Powers M, Rich GM, Gutkin M, Fallo F, et al.: Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nat Genet 1992, 2:66-74.
12. Pascoe L, Curnow KM, Slutsker L, Rosier A, White PC: Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyloxldase II deficiency. Proc Natl Acad Sci U S A 1992, 89:4996-5000.
13. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, et al.: A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992, 355:262-265.
14. Kramer RE, Rainey WE, Funkenstein B, Dee A, Simpson ER, Waterman MR: Induction of synthesis of mitochondrial steroidogenic enzymes of bovine adrenocortical cells by analogs of cyclic AMP. J Biol Chem 1984, 259:707-713.
15. Curnow KM, Tusie-Luna MT, Pascoe L, Natarajan R, Gu JL, Nadler JL, et al.: The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex. Mol Endocrinol 1991, 5:1513-1522.
16. Staels B, Hum DW, Miller WL: Regulation of steroidogenesis in NCI-H295 cells: a cellular model of the human fetal adrenal. Mol Endocrinol 1993, 7:423-433.
17. Denner K, Rainey WE, Pezzi V, Bird IM, Bernhardt R, Mathis JM: Differential regulation of 11 beta-hydroxylase and aldosterone synthase in human adrenocortical H295R cells. Mol Cell Endocrinol 1996, 121:87-91.
18. Ogishima T, Shibata H, Shimada H, Mitani F, Suzuki H, Saruta T, Ishimura Y: Aldosterone synthase cytochrome P-450 expressed in the adrenals of patients with primary aldosteronism. J Biol Chem 1991, 266:10731-10734.
19. Kwan-Dun WU, Yung-Ming C, Jan-Show C, Kuan-Yu, The-Sheng H, Bor-Shen H: Zona fasciculata-like cells determine the response of plasma aldosterone to metoclopramide and aldosterone synthase messenger ribonucleic acid level in aldosterone-producing adenoma. J Clin Endocrinol Metab 1995, 80:783-788.
20. Tremblay A, Parker KL, Lehoux J: Dietary potassium supplementation and sodium restriction stimulate aldosterone synthase but not 11 beta-hydroxylase P-450 messenger ribonucleic acid accumulation in rat adrenals and require ANG II production. Endocrinology 1992, 130:3152-3158.
21. Holland OB, Carr B: Modulation of aldosterone synthase messenger ribonucleic acid levels by dietary sodium and potassium and by adrenocorticotropin. Endocrinology 1993, 132:2666-2673.
22. Adler GK, Chen R, Menachery AI, Braley LM, Williams GH: Sodium restriction increases aldosterone biosynthesis by increasing late pathway, but not early pathway, messenger ribonucleic acid levels and enzyme activity in normotensive rats. Endocrinology 1993, 133:2235-2240.
23. Scheumann GFW, Heitmann P, Teebken OE, Mosinger E, Mellon SH, Pichlmayr R: Enzymatic properties of transplanted glomerulosa cells. World J Surg 1996, 20:933-939.
24. Thomas M, Northrup SR, Hornsby PJ: Adrenocortical tissue formed by transplantation of normal clones of bovine adrenocortical cells in SCID mice replaces the essential functions of the animals' adrenal glands. Nat Med 1997, 3:978-983. This study extends the findings of Scheumann et al. (World J Surg 1996, 20:933-939) and demonstrates that adrenal cells of clonal origin can therapeutically replace the necessary glucocorticoids in animals that have undergone adrenalectomy. Using this model, researchers can proceed to define the mechanisms controlling the zonation of the adrenal gland and the ability of clonal cells to recapitulate all three of the zones.
25. Thomas M, Northrup SR, Hornsby PJ: Adrenocortical tissue formed by transplantation of normal clones of bovine adrenocortical cells in SCID mice replaces the essential functions of the animals' adrenal glands. Nat Med 1997, 3:978-983. This study extends the findings of Scheumann et al. (World J Surg 1996, 20:933-939) and demonstrates that adrenal cells of clonal origin can therapeutically replace the necessary glucocorticoids in animals that have undergone adrenalectomy. Using this model, researchers can proceed to define the mechanisms controlling the zonation of the adrenal gland and the ability of clonal cells to recapitulate all three of the zones.
26. Honda S, Morohashi K, Omura T: Novel cAMP regulatory elements in the promoter region of bovine P450(11β) gene. J Biochem 1990, 108:1042-1049.
27. Rice BA, Aitkan LD, Vandedbark GR, Mouw AR, Franklin A, Schimmer BP, Parker KL: A cAMP-responsive element regulates expression of the mouse steroid 11β-hydroxylase gene. J Biol Chem 1989, 264:14011-14015.
28. Mukai K, Imai M, Shimada H, Ishimura Y: Isolation and characterization of rat CYP11B genes Involved in late steps of mineralo-and glucocorticoid syntheses. J Biol Chem 1993, 268:9130-9137.
29. Clyne CD, White PC, Rainey WE: Calcium regulates human CYP11B2 transcription. Endocr Res 1996, 22:485-492.
30. Coulombe N, Lefebvre A, Lehoux JG: Characterization of the hamster CYP11B2 gene encoding adrenal cytochrome P450 aldosterone synthase. DNA Cell Biol 1997, 16:993-1002. This is part of a series of studies characterizing the hamster adrenal steroidogenic enzymes and receptors. In this study a possible inhibitory element in the hamster CYP11B2 gene is noted at position -143. The authors, however, note a lack of calcium response in the Y-1 cell model as noted by Clyne et al. (Endocr Res 1996, 22:485-492).
31. Coulombe N, Lefebvre A, Lehoux JG: Characterization of the hamster CYP11B2 gene encoding adrenal cytochrome P450 aldosterone synthase. DNA Cell Biol 1997, 16:993-1002. This is part of a series of studies characterizing the hamster adrenal steroidogenic enzymes and receptors. In this study a possible inhibitory element in the hamster CYP11B2 gene is noted at position -143. The authors, however, note a lack of calcium response in the Y-1 cell model as noted by Clyne et al. (Endocr Res 1996, 22:485-492).
32. Mellon SH, Miller WL, Bair SR, Moore CC, Vigne JL, Weiner RI: Steroidogenic adrenocortical cell lines produced by genetically targeted tumorigenesis in transgenic mice. Mol Endocrinol 1994, 8:97-108.
33. Compagnone NA, Bair SR, Mellon SH: Characterization of adrenocortical cell lines produced by genetically targeted tumorigenesis in transgenic mice. Steroids 1997, 62:238-243.
34. Gazdar AF, Oie HK, Shackleton CH, Chen TR, Triche TJ, Myers CE, et al.: Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis. Cancer Res 1990, 50:5488-5496, 1990.
35. Bird IM, Hanley NA, Word RA, Mathis JM, McCarthy JL, Mason JI, et al.: Human NCI-H295 adrenocortical carcinoma cells: a model for angiotensin-II-responsive aldosterone secretion. Endocrinology 1993, 133:1555-1556.
36. Rainey WE, Bird IM, Sawetawan C, et al: Regulation of human adrenal carcinoma cell (NCI-H295) production of C19 steroids. J Clin Endocrinol Metab 1993, 77:731-737.
37. Rainey WE, Bird IM, Mason JI: The NCI-H295 cell line: a pluripotent model for human adrenocortical studies. Mol Cell Endocrinol 1994, 100:45-50.
38. Rainey WE, Mrotek JJ: Human adrenocortical cell lines: model systems to study steroid hormone synthesis. In Human Cell Culture, Vol 1: Human Cancer Cell Lines. Edited by Masters J. Dordrecht: Kluwer Academic Press; 1998: in press.
39. Rogriquez H, Hum DW, Staels B, Miller WL: Transcription of the human genes for cytochrome P450scc and P450c17 is regulated differently in human adrenal NCI-H295 cells than in mouse adrenal Y1 cells. J Clin Endocrinol Metab 1997, 82:365-371.
40. 2+-regulated expression of steroid hydroxylases in H295R human adrenocortical cells. Endocrinology 1995, 136:5677-5684.
41. Miller WL: Molecular biology of steroid hormone synthesis. Endocr Rev 1988, 9:295-318.
42. Waterman MR, Bischof U: Diversity of ACTH (cAMP)-dependent transcription of bovine steroid hydroxylase genes. FASEB J 1997, 11:419-427.
43. Allen RG, Carey C, Parker JD, Mortrud MT, Mellon SH, Low MJ: Targeted ablation of pituitary pre-proopiomelanocortin cells by herpes simplex virus-1 thymidine kinase differentially regulates mRNAs encoding the adrenocorticotropin receptor and aldosterone synthase in the mouse adrenal gland. Mol Endocrinol 1995, 9:1005-1016.
44. Fuchs-Hammoser R, Schweigwe M, Oelkers W: The effect of chronic low-dose infusion of ACTH (1-24) on renin, renin substrate, aldosterone and other corticosteroids in sodium replete and deplete man. Acta Endocrinol 1980, 95:198-206.
45. Aguilera G, Fujita K, Catt KJ: Mechanisms of inhibition of aldosterone secretion by adrenocorticotropin. Endocrinology 1981, 108:522-528.
46. Abayasekara DR, Vazir H, Whitehouse BJ, Price GM, Hinson JP, Vinson GP: Studies on the mechanisms of ACTH-induced inhibition of aldosterone biosynthesis in the rat adrenal cortex. J Endocrinol 1989, 122:625-632.
47. Aguilera G, Kiss A, Lu A, Camacho C: Regulation of adrenal steroidogenesis during chronic stress. Endocr Res 1996, 22:433-443.
48. Mitani K, Miyamoto H, Mukai K, Ishimura Y: Effects of long term stimulation of ACTH-and angiotensin II secretions on the rat adrenal cortex. Endocr Res 1996, 22:421-431.
49. Andoka G, Chauvin MA, Marie J, Saez JM, Morera AM: Adrenocorticotropin regulates angiotensin II receptors in bovine adrenal cells in vitro. Biochem Biophys Res Commun 1984, 121:441-447.
50. Yoshida A, Nishidawa T, Tamura Y, Yoshida S: ACTH-induced inhibition of the action of angiotensin II in bovine zona glomerulosa cells: a modulatory effect of cyclic AMP on the angiotensin II receptor. J Biol Chem 1991, 266:4288-4294.
51. Bird IM, Mason JI, Rainey WE: Regulation of type 1 angiotensin II receptor messenger ribonucleic acid expression in human adrenocortical carcinoma H295R cells. Endocrinology 1994, 134:2468-2474.
52. McAllister JM, Hornsby PJ: Dual regulation of 3 beta-hydroxysteroid dehydrogenase, 17 alpha-hydroxylase, and dehydroepiandrosterone sulfotransferase by adenosine 3′, 5′-monophosphate and activators of protein kinase C in cultured human adrenocortical cells. Endocrinology 1988, 122:2012-2018.
53. Bird IM, Pasquarette MM, Rainey WE, Mason JI: Differential control of 17 alpha-hydroxylase and 3 beta-hydroxysteroid dehydrogenase expression in human adrenocortical H295R cells. J Clin Endocrinol Metab 1996, 81:2171-2178.
54. Xia Y, Wikberg JES: Localization of ACTH receptor mRNA by in situ hybridization in mouse adrenal gland. Cell Tissue Res 1996, 286:63-68.
55. Hausdorff WP, Sekura RD, Aguilera G, Catt KJ: Control of aldosterone production by angiotensin II is mediated by two guanine nucleotide regulatory proteins. Endocrinology 1987, 120:1668-1678.
56. Begeot M, Langlois D, Penhoat A, Saez JM: Variations in guanine-binding proteins (Gs, Gi) in cultured bovine adrenal cells: consequences on the effects of phorbol ester and angiotensin II on adrenocorticotropin-induced and cholera-toxin-induced cAMP production. Eur J Biochem 1988, 174:317-321.
57. Shen T, Suzuki Y, Poyard M, Best-Belpomme M, Defer N, Hanoune J: Localization and differential expression of adenylyl cyclase messenger ribonucleic acids in rat adrenal gland determined by in situ hybridization. Endocrinology 1997, 138:4591-4598.
58. Okubo S, Miimura F, Nishimura H, Takemoto F, Fogo A, Matsusaka T, Ichikawa I: Angiotensin-independent mechanism for aldosterone synthesis during chronic extracellular fluid volume depletion. J Clin Invest 1997, 99:855-860.
59. Chen XM, Li WG, Yoshid H, Tsuchida S, Nishimura H, Takemoto F, et al.: Targeting deletion of angiotensin type 1B receptor gene in the mouse. Am J Physiol 1997, 41:F299-F304.
60. Yagci A, Oertle M, Seiler H, Schmid D, Campofranco C, Müller J: Potassium induces multiple steroidogenic enzymes in cultured rat zona glomerulosa cells. Endocrinology 1996, 137:2406-2414.
61. Yagci A, Müller J: Induction of steroidogenic enzymes by potassium in cultured rat zona glomerulosa cells depends on calcium influx and intact protein synthesis. Endocrinology 1996, 137:4331-4338.
62. Pezzi V, Clyne CD, Ando S, Mathis JM, Rainey WE: Ca(2+)-regulated expression of aldosterone synthase is mediated by calmodulin and calmodulin-dependent protein kinases. Endocrinology 1997, 138:835-838.
63. Clyne CD, Zhang Y, Slutsker L, Mathis MM, White PC, Rainey WE: Angiotensin II and potassium regulate human CYP11B2 transcription through common cis-elements. Mol Endocrinol 1997, 11:638-649.
64. Weinstein H, Mehler EL: Ca(2+)-binding and structural dynamics in the functions of calmodulin. Annu Rev Physiol 1994, 56:213-236.
65. Schulman H, Hanson PI: Multifunctional Ca2+/calmodulin-dependent protein kinase. Neurochem Res 1993, 18:65-77.
66. Kakiki M, Morohashi K, Nomura M, Omura T, Horie T: Regulation of aldosterone synthase cytochrome P450 (CYP11B2) and 11-beta-hydroxylase cytochrome P450 (CYP11B1) expression in rat adrenal zona glomerulosa cells by low sodium diet and angiotensin II receptor antagonists. Biol Pharm Bull 1997, 20:962-968.
67. Kakiki M, Morohaski K, Nomura M, Omura T, Horie T: Expression of aldosterone synthase cytochrome P450 (P450aldo) mRNA in rat adrenal glomerulosa cells by angiotensin II type-1 receptor. Endocr Res 1997, 23:277-295.
68. Breault L, Lehoux J-G, Gallo-Payet N: Angiotensin II receptors in the human adrenal gland. Endocr Res 1996, 22:355-361.
69. Mukai K, Mitani F, Shimada H, Ishimura Y: Involvement of an AP-1 complex in zone-specific expression of the CYP11B1 gene in the rat adrenal cortex. Mol Cell Biol 1995, 15:6003-6012.
70. Rice DA, Mouw AR, Bogerd AM, Parker KL: A shared promoter element regulates the expression of three steroidogenic enzymes. Mol Endocrinol 1991, 5:1552-1561.
71. Lala DS, Rice DA, Parker KL: Steroidogenic factor I, a key regulator of steroidogenic enzyme expression, is the mouse homolog of fushi tarazu-factor I. Mol Endocrinol 1992, 6:1249-1258.
72. Morohashi K, Honda S, Inomata Y, Handa H, Omura T: A shared promoter element regulates the expression of three steroidogenic enzymes. Mol Endocrinol 1992, 5:1552-1561.
73. Ingraham HA, Lala DS, Ikeda Y, Luo X, Shen W-H, Nachtigal MW, et al.: The nuclear receptor SF-1 acts at multiple levels of the reproductive axis. Genes Dev 1994, 8:2302-2312.
74. Wang LH, Tsai SY, Cook RG, Beattie WG, Tsai MJ, O'Malley BW: COUP transcription factor is a member of the steroid receptor superfamily. Nature 340:163-166.
75. White PC, Slutsker L: Haplotype analysis of CYP11B2. Endocr Res 1995, 21:437-442.
76. Clot F, Jager M, Simon-Bouy B, Serre JL, Aupetit-Faisant B, Mornet E: A polymorphic poly-A sequence in the 5′ region of the aldo synthase (CYP11B2) gene may be useful in genetic diagnosis of 11 beta-hydroxylase genes defects. Hum Genet 1994, 94:316-317.
77. Tusie-Luna MT, White PC: Gene conversions and unequal crossovers between CYP21 (steroid 21-hydroxylase gene) and CYP21P involve different mechanisms. Proc Natl Acad Sci U S A 1995, 92:10796-10800.
78. Fardella CE, Rodriguez H, Montero J, Zhang G, Vignolo P, Rojas A, Villarroel L, Miller WL: Genetic variation in P450c11AS in Chilean patients with low renin hypertension. J Clin Endocrinol Metab 1996, 81:4347-4351.
79. Globerman H, Rosler A, Theodor R, New MI, White PC: An inherited defect in aldosterone biosynthesis caused by a mutation in or near the gene for steroid 11-hydroxylase [abstract]. N Engl J Med 1988, 319:1193-1197.
80. Benetos A, Poirier O, Guyene TT, Gautier S, Pojoga L, Cambien F: Genetic determination of plasma aldosterone levels [abstract]. Hypertension 1997, 30:A493.
81. Kupari M, Hautanen A, Lankinen L, Koskinen P, Virolainen J, Nikkila H, White PC: Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass and function. Circulation 1988, 97:569-575.
82. Brilla CG, Matsubara LS, Weber KT: Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J Mol Cell Cardiol 1993, 25:563-575.
83. Young M, Fullerton MJ, Dilley R, Funder JW: Mlneralocorticoids, hypertension, and cardiac fibrosis. J Clin Invest 1994, 93:2578-2583.
84. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study [see comments]. N Engl J Med 1990, 322:1561-1566.
85. Lauer MS, Evans JC, Levy D: Prognostic implications of subclinical left ventricular dilatation and systolic dysfunction in men free of overt cardiovascular disease (the Framingham Heart Study). Am J Cardiol 1992, 70:1160-1184.
86. LaRovere MT, Bigger JT, Marchs FI, Montara A, Schwartz PJ, for ATRAMI Investigators: Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 1998, 351:478-484.